Alexsis de Raadt-St. James
Founder and Funder @ WEInnovate Accelerator at Imperial Enterprise Lab
San Francisco, United States
Alexsis de Raadt-St. James is a seed investor at WEInnovate Accelerator at Imperial Enterprise Lab in San Francisco focused on Software and SaaS. Alexsis is the Founder and Managing Partner of Merian Ventures, an early-stage venture firm focused on investing in women founded, co-founded and majority-owned companies in the US and UK. Alexsis has extensive investment, venture and operations experience based on businesses she has founded or funded. As managing partner of Merian Ventures since2015, Alexsis serves as a Board Member and Advisor to Merian Venture portfolio companies Provenance, Pivigo, Populus, Honeycomb, ImpactVision, CareerLark, Cirrus Identity and Compaas, among others. Merian Ventures was named after Maria Sibylla Merian, a botanist, entrepreneur and intrepid traveler born in 1647. In addition to Merian Ventures, Alexsis is a US-UK Fulbright Commissioner; Board member of the Oxford Internet Institute; Board member of The Oxford Foundry; Founder and funder of the WEInnovate STEM accelerator for Women at Imperial College, London; and Board Member and Advisor to companies she's funded. Alexsis is also Chairman and Founder of The Althea Foundation, established in 2003 as a family office. Today, The Althea Foundation is a California nonprofit public benefit corporation and it is recognized by the Internal Revenue Service as a public charity described in Internal Revenue Code Sections 501(c)(3) and 509(a)(1).
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Alexsis de Raadt-St. James invests in
Stages Alexsis de Raadt-St. James invests in
Countries Alexsis de Raadt-St. James invests in
Round sizes
Round size
- Seed
- $250k–$2.9M
- Series A
- $2.1M–$24M
Investment Focus
Industry
- Software 5 (63%)
- SaaS 2 (25%)
- Health Care 2 (25%)
- Artificial Intelligence 2 (25%)
- Mobile 1 (13%)
Stage
- Seed 4 (50%)
- Series A 3 (38%)
- Series B 1 (13%)
Country
- United States 6 (75%)
- Switzerland 1 (13%)
- United Kingdom 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aiden
|
Aiden develops software packages supported by an AI bot that automates tasks and enhances security management. The system ensures that computers receive the required software while excluding unnecessary programs. It is designed to streamline IT processes and reduce manual intervention. | $2.9M / Seed / Jun 08, 2021 | |
Compaas
|
Compaas helps growing companies make smarter decisions around compensation, communicate better with their employees, and avoid mistakes.It offers a Compensation Intelligence Platform that helps companies manage their operating expense: employee compensation. The platform provides compensation analytics and strategy tools for startups andenterprise companies.In 2017, Lisa Dusseault and Bethanye Blount founded the company in San Francisco, California. | Seed / Mar 20, 2018 | |
Provenance
|
The trusted data layer for agentic commerce. Provenance powers enriched product attributes for 300+ brands and retailers, including L’Oreal, Holland & Barrett, THG, Nestle, Unilever, LVMH, Diageo and Ocado, positioning it as a trusted infrastructure layer for AI discovery and values-driven commerce.With AI-driven commerce projected to reach$3–5 trillion by 2030, brands and retailers face a structural challenge: product claims are largely unstructured, unverifiable and lacking trust signals for AI systems. Provenance converts complex product data - certifications, sustainability, health and efficacy claims - into verified, machine-readable claims that AI systems can reliably interpret and cite, building on over a decade of domain expertise in the integrity, validation and compliance of CPG product claims. | $800K / Seed / Jul 11, 2017 | |
Cirrus Identity
|
Cirrus Identity is the Swiss army knife of cloud-hosted digital identity management solutions. Our solutions are best in class for integrating social login (Google, Facebook, LinkedIn) with enterprise Web Single Sign-On. This greatly streamlines access for "guest" account holders, such as contractors and volunteers in enterprise. Commonhigher education users include alumni, parents, and applicants. We have 40 enterprise customers including some of the top universities in the country, including Yale, the University of Michigan, the University of Chicago, UC Berkeley, Carnegie Mellon and Brown University. | $250K / Seed / Sep 28, 2016 | |
Neurona Therapeutics
|
Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs. | $23.5M / Series A / Dec 01, 2015 | |
dacadoo
|
dacadoo is a global technology company that is driving the digital transformation in healthcare. Based in Zurich, Switzerland, dacadoo strengthens health and wellbeing through active engagement and artificial intelligence. dacadoo develops and operates a mobile-first digital health engagement platform that helps people live healthier, more activelives through a combination of motivational techniques from behavioral science, online gaming and social networks, as well as artificial intelligence and automated coaching. Based on over 300 million person-years of clinical data, its patented, real-time Health Score makes health individually measurable, which provides users with a unique engagement experience, while also offering dacadoo’s enterprise customers an effective way to measure the true health impact of wellness programs. Available in 15 languages, dacadoo’s technology is provided as a fully branded, white-label solution or it can be integrated into customer products through its API. dacadoo’s customers include health and life insurance companies, health & wellness service organizations as well as large and mid-sized employers for health promotion in the workplace. | Series A / Jun 08, 2015 | |
CapLinked
|
CapLinked’s intuitive, cloud-based platform makes it easier to manage and close business transactions. CapLinked enables its customers to coordinate on asset sales, financings, mergers & acquisitions, and other types of complex deals with secure workspaces. Customers can manage and syndicate deals, conduct due diligence, handle investorreporting, and network with other users. | $2.1M / Series A / Nov 29, 2012 | |
Everdream
|
Everdream Corporation provides on-demand personal computer desktop management software services internationally. It offers compliance software services suite that provides visibility into hardware and software assets, tracks software license usage, and automates the distribution of software to ensure regulatory compliance to the computers; anduptime software services suite that provides protection against Internet attacks, hackers, and loss of critical data through malware protection, patch management, and online data backup services. The company also provides information technology support software services, such as on-demand employee service desk solutions and remote control services, as well as offers managed services. Everdream Corporation has operational facilities in Dallas, Texas; and Charlotte, North Carolina. The company was founded in 1998 and is headquartered in Fremont, California. As of December 20, 2007, Everdream Corporation operates as a subsidiary of Dell Inc. | $15.5M / Series B / Jan 04, 2000 |
Co-Investors
About WEInnovate Accelerator at Imperial Enterprise Lab
Accelerator for female-led startups
WEInnovate Accelerator at Imperial Enterprise Lab Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alexsis de Raadt-St. James
Founder and Funder
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Alexsis de Raadt-St. James invest in?
Alexsis de Raadt-St. James invests primarily in Software, SaaS and Health Care startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Alexsis de Raadt-St. James's check size?
Alexsis de Raadt-St. James typically joins rounds of $250k–$2.9M at Seed and $2.1M–$24M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Alexsis de Raadt-St. James participates in.
When did Alexsis de Raadt-St. James last invest?
The most recent investment recorded for Alexsis de Raadt-St. James closed in Jun 2021. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
